Delta-Fly Pharma, Inc. (4598) Income Statement

Last quarter (Q1 2026), Delta-Fly Pharma, Inc.'s total revenue was ¥0.00, a decrease of ― from the same quarter last year. In Q1, Delta-Fly Pharma, Inc.'s net income was ¥-367.06M. See Delta-Fly Pharma, Inc.’s key income statements, including revenue, expenses, profit, and income.